Journal of Clinical Oncology , 0732-183X

Journal

71 - 80 out of 120Page size: 10

Publications

  1. 2009
  2. Published

    Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial

    Nicholas James, 2009, In: Journal of Clinical Oncology . 27, 32, p. 5431-8 8 p.

    Research output: Contribution to journal › Article › peer-review

  3. Published

    Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group

    Gary Middleton, 2009, In: Journal of Clinical Oncology . 27, 23, p. 3786-93 8 p.

    Research output: Contribution to journal › Article › peer-review

  4. 2008
  5. Published

    New Utility of an Old Marker: Serial  -Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemotherapy

    Philip Johnson, 15 Dec 2008, In: Journal of Clinical Oncology. 27, 3, p. 446-452 7 p.

    Research output: Contribution to journal › Article

  6. Published

    Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: Report by the Colorectal Adenoma/Carcinoma Prevention Programme 2

    Eamonn Maher, Jonathan Mathers, 1 Jul 2008, In: Journal of Clinical Oncology. 26, 20, p. 3434-3439 6 p.

    Research output: Contribution to journal › Article

  7. Published

    EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer

    Gary Middleton, 2008, In: Journal of Clinical Oncology . 26, 14, p. 2311-9 9 p.

    Research output: Contribution to journal › Article › peer-review

  8. 2007
  9. Published

    Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients.

    Natalie Rowland, Becky Harrison & Keith Wheatley, 1 Dec 2007, In: Journal of Clinical Oncology. 25, 34, p. 5426-34 9 p.

    Research output: Contribution to journal › Article

  10. Published

    Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion

    Judy Powell, Malcolm Taylor, Paul Moss & Tatjana Stankovic, 1 Dec 2007, In: Journal of Clinical Oncology. 25, 34, p. 5448-57 10 p.

    Research output: Contribution to journal › Article

  11. Published

    Rational Selection of Patients for Antibacterial Prophylaxis After Chemotherapy

    Lucinda Billingham & Neil Steven, 20 Oct 2007, In: Journal of Clinical Oncology. 25, 30, p. 4821-4828 8 p.

    Research output: Contribution to journal › Article

  12. Published

    End Points for Colon Cancer Adjuvant Trials: Observations and Recommendations Based on Individual Patient Data From 20,898 Patients Enrolled Onto 18 Randomized Trials From the ACCENT Group

    Richard Gray, 10 Oct 2007, In: Journal of Clinical Oncology. 25, 29, p. 4569-4574 6 p.

    Research output: Contribution to journal › Article

  13. Published

    Does adjuvant vaccine therapy really have activity in malignant melanoma?

    Keith Wheatley, Natalie Rowland, 1 Oct 2007, In: Journal of Clinical Oncology. 25, 29, p. 4693-4693 1 p.

    Research output: Contribution to journal › Article

Previous 1...4 5 6 7 8 9 10 11 12 Next